Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
2.
Res Vet Sci ; 105: 153-9, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27033925

ABSTRACT

The purpose of this pilot study was to evaluate the usefulness of selected echocardiographic parameters, NT-proBNP and cardiac troponin I (cTnI) in the detection of cardiotoxicity in dogs treated with doxorubicin for various malignancies. Echocardiographic studies and biomarker measurements were performed before each administration of doxorubicin, then 1 and 3 months after completion of therapy. Thirteen dogs were included, with a total cumulative dose of doxorubicin ranging from 30 to 150 mg/m(2). E/A ratio significantly decreased during doxorubicin administration (p=0.047). cTnI level was also significantly affected by treatment (p=0.046), increasing above normal at least at one time point in 11 of 13 dogs. The results of this pilot study suggest that monitoring of left ventricular diastolic function and cTnI level measurement might be useful in the early detection of cardiotoxic signs of doxorubicin therapy in dogs.


Subject(s)
Antibiotics, Antineoplastic/toxicity , Cardiotoxicity/veterinary , Doxorubicin/toxicity , Echocardiography, Doppler/veterinary , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Troponin I/blood , Ventricular Function, Left , Animals , Biomarkers/blood , Cardiotoxicity/diagnosis , Diastole , Dogs , Echocardiography, Doppler/methods , Female , Male , Neoplasms/drug therapy , Pilot Projects , Prospective Studies
3.
Bone Marrow Transplant ; 11(2): 177-9, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8382096

ABSTRACT

A 41-year-old recipient of matched unrelated BMT acquired a severe mucocutaneous herpes simplex virus (HSV) type I infection during acyclovir prophylaxis. He was subsequently treated with high-dose acyclovir, but the HSV infection continued. In vitro analysis of the HSV isolate, obtained before and after the administration of high-dose acyclovir, demonstrated marked resistance to acyclovir but sensitivity to the antiviral agent foscarnet. The mucocutaneous HSV infection healed completely to a 16 day course of foscarnet. However, relapse of the acyclovir-resistant HSV infection occurred 202 days after the first foscarnet treatment but he responded again to a second foscarnet course. These data indicate that, with the rising frequency of acyclovir-resistant HSV infections observed in immunocompromised hosts, viral isolates should be tested for susceptibility to different antiviral drugs in recipients of BMT with recurrent or persistent HSV infections.


Subject(s)
Bone Marrow Transplantation , Foscarnet/therapeutic use , Herpes Simplex/drug therapy , Acyclovir/therapeutic use , Adult , Animals , Chlorocebus aethiops , Esophagitis/drug therapy , Esophagitis/microbiology , Humans , Male , Recurrence , Simplexvirus/drug effects , Transplantation, Homologous , Vero Cells/microbiology
4.
Ann Hematol ; 64 Suppl: A162-5, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1322190

ABSTRACT

The relationship between Epstein-Barr virus (EBV) and the host is profoundly disturbed by allogeneic bone marrow transplantation (BMT) because EBV resides in the recipient's hematopoietic system, which has to be destroyed in the majority of cases, and in the donor's hematopoietic system, i.e., the marrow graft. We have shown that EBV may be eradicated from some BMT recipients and that the virus may be transferred with the marrow graft. During the immediate post-transplant period oropharyngeal EBV excretion may occur which, by infecting passing B lymphocytes, may act as co-factor for acute graft-versus-host disease and help the virus to survive, despite the temporary depletion of its reservoir. The coexistence of totally different EBV strains in BMT recipients but not in healthy, untransfused controls, suggests that superinfection may by possible in case of immunodeficiency; alternatively, transfer of the virus by the reservoir itself (the B lymphocytes) might be the only effective route for superinfection. The generation of 'variant' strains during viral replication may form the basis of the vast polymorphism between wild-type EBV isolates in the population.


Subject(s)
Bone Marrow Transplantation , Herpesviridae Infections/blood , Herpesvirus 4, Human , Adolescent , Adult , Bone Marrow/microbiology , Child , Child, Preschool , Herpesvirus 4, Human/isolation & purification , Humans , Immunoblotting , Infant , Middle Aged
5.
Am J Pathol ; 136(5): 1093-9, 1990 May.
Article in English | MEDLINE | ID: mdl-2161617

ABSTRACT

In contrast to its role in B-lymphomagenesis, Epstein-Barr Virus (EBV) only incidentally has been associated with T-cell lymphomas. In the present report we describe a fourth patient with EBV-related T-cell lymphoma. The patient presented with an angio-immunoblastic lymphadenopathy (AILD)-like T-cell lymphoma. Serology was compatible with chronic Epstein-Barr (EBV) infection. After a 1-year period of waxing and waning lymphadenopathy, this lymphoma evolved to an aggressive CD8+ Immunoblastic T-cell lymphoma. A relationship with the chronic EBV infection was indicated by the finding of EBV genome in the tumor tissue by Southern blot analysis. Moreover, EBV nuclear antigen (EBNA) was detected in situ within individually defined CD8+ tumor cells by two-color immunofluorescence. Two alternative possibilities, namely that EBV primarily played a role in lymphomagenesis of the AILD-like T-cell lymphoma or that the virus was an additional oncogenic event in the final process of tumor progression to the immunoblastic lymphoma, are discussed.


Subject(s)
Antigens, Differentiation, T-Lymphocyte/analysis , Herpesvirus 4, Human/analysis , Lymphoma/microbiology , Adult , Antigens, CD/analysis , Antigens, Viral/analysis , CD8 Antigens , Cell Nucleus/immunology , DNA, Viral/analysis , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/immunology , Humans , Lymph Nodes/pathology , Lymphoma/immunology , Lymphoma/pathology , Male , T-Lymphocytes
6.
Transplantation ; 49(4): 725-30, 1990 Apr.
Article in English | MEDLINE | ID: mdl-2158159

ABSTRACT

We have shown in two allogeneic bone marrow transplant recipients that Epstein-Barr virus can be eradicated by the BMT procedure or its complications, and that these patients are susceptible to infection with a new EBV strain. This conclusion was based on a combination of EBV serology and virus strain identification ("Ebnotyping," using the size variations of 5 EBV nuclear antigens). In the present study, we conducted a serological survey of EBV infection in 153 marrow graft recipients and their donors. Ten patients who were positive for IgG antibodies against EBV viral capsid antigens prior to BMT became completely seronegative at a median of 197 days post-BMT (range 106-320 days). Four of these patients, who had received seronegative marrow, remained seronegative during prolonged periods (222 to 2105 days). Six patients had received seropositive marrow. Two of them remained seronegative during their subsequent periods of follow-up (895 and 1437 days). An additional 10 patients showed a 100-fold or greater decrease in VCA IgG antibody titers. Their titers reached a nadir of 10 (the lower limit of positive) at a median of 134 days post BMT (range 83-386 days). The serological patterns of the above 20 patients were particularly frequent among patients with chronic graft-versus-host disease; 12 of 20 patients with decreasing VCA titers (60%) developed chronic GVHD versus only 22 of 73 patients with stable or increasing VCA titers (30%). These results suggest that GVHD may contribute to the elimination of residual EBV-carrying recipient cells. Establishment of EBV-carrying lymphoblastoid cell lines (LCL) was attempted in 60 donor-recipient pairs whose cryopreserved peripheral blood mononuclear cells were available. LCL were established from 18 of 51 EBV-seropositive marrow donors and 10 of 57 seropositive recipients prior to BMT. The same EBV strain was detected in 4 of the 6 cases in which LCL could be established from both the donor and the recipient prior to BMT. The persistence of the original EBV strain was demonstrated in a recipient of a T cell-depleted graft who showed only transient hematological recovery and no GVHD, and was associated with the persistence of B cells of recipient origin.


Subject(s)
Bone Marrow Transplantation/immunology , Herpesviridae Infections/immunology , Herpesvirus 4, Human/immunology , Adolescent , Adult , Antibodies, Viral/blood , Child , Child, Preschool , DNA, Viral/analysis , Graft vs Host Disease/immunology , Herpesviridae Infections/microbiology , Herpesvirus 4, Human/classification , Herpesvirus 4, Human/isolation & purification , Humans , Infant , Middle Aged
7.
Rev Med Interne ; 10(5): 475-81, 1989.
Article in French | MEDLINE | ID: mdl-2488496

ABSTRACT

According to recent studies, vitamin D deficiency may contribute to the osteoporosis observed in elderly subjects, with reduced intestinal calcium absorption and secondary hyperparathyroidism. Vitamin D deficiency is often present in elderly people, due to inadequate diet and confinement at home. The administration of either oral vitamin D in doses of 4,000 IU per day, or six-monthly intramuscular injections of ergocalciferol 600,000 IU, combined with a daily intake of at least 1 g of calcium brings back to normal both 25 OH D concentrations and parathyroid hormone levels. When pursued for one year, these treatments also maintain the formation of cortical bone, as shown by the metacarpal index. As for the concentration of 25 OH D, it seems that 60 to 75 nmol/l are necessary to restore calcium homeostasis. The dietary habits of elderly people are such that a supplement of medicinal calcium is required. Finally, we regard the parenteral form of ergocalciferol as being preferable to the oral form at that age for better compliance with treatment.


Subject(s)
Calcium/metabolism , Osteoporosis/prevention & control , Phosphorus/metabolism , Vitamin D/administration & dosage , Administration, Oral , Aged , Aged, 80 and over , Double-Blind Method , Female , Humans , Male , Vitamin D/pharmacology
9.
Proc Natl Acad Sci U S A ; 85(22): 8693-6, 1988 Nov.
Article in English | MEDLINE | ID: mdl-2847171

ABSTRACT

Wild-type strains of Epstein-Barr virus (EBV) can be distinguished on the basis of variations in the molecular weight of virus-encoded, growth transformation-associated proteins. This approach was used to study the persistence of EBV in two seropositive recipients of allogeneic bone marrow transplants. The first patient received marrow from her EBV-seronegative brother, became EBV seronegative after grafting, and remained so for greater than 1200 days. Subsequently, she became infected with a new EBV strain that differed from her pretransplant strain but was indistinguishable from the virus isolated from her husband. The second patient received marrow from his EBV-seropositive brother. This patient showed only a transient decrease in IgG antibodies to EBV capsid antigen. His pretransplant strain differed from the virus of his donor. On days 252 and 915 after transplantation, lymphoblastoid cell lines were grown from the peripheral blood of the patient and were found to carry exclusively the virus of the donor. These results suggest that the latently EBV-infected host cells reside in a cellular compartment that can be destroyed by graft-versus-host reactivity, irradiation, or cytotoxic drugs. Hemopoietic tissue is the most likely candidate.


Subject(s)
Bone Marrow Transplantation , Herpesvirus 4, Human/isolation & purification , Adult , Antigens, Viral/analysis , Epstein-Barr Virus Nuclear Antigens , Female , Graft vs Host Disease , Herpesvirus 4, Human/immunology , Humans , Leukemia, Myeloid, Acute/therapy , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy , Transplantation, Homologous
10.
Rev Med Interne ; 9(3): 249-55, 1988.
Article in French | MEDLINE | ID: mdl-3406585

ABSTRACT

Calcium and phosphorus metabolism was studied in 101 institutionalized subjects over 70 years of age (mean: 82.5 years). The study was performed in serum and urine; it included parathyroid hormone and calcidiol (250HD3) assays and radiological examination of bones with determination of Meunier's index and metacarpal cortical index. Calcidiol concentrations did not vary with age but were higher in people who left the institution and in men. In contrast, there was a significant age-group related increase of parathyroid hormone concentrations. This increase was accompanied by an increase of parathyroid hormone activity, as shown by a parallel fall in phosphorus reabsorption rate. These findings are in agreement with current pathogenetic theories on senile osteoporosis. Invalid subjects had higher urinary calcium and serum parathyroid hormone levels and a lower cortical index. Paradoxically, there was less vertebral collapse as evaluated by Meunier's index, which may suggest that very old patients develop progressive cortical bone hyperresorption entirely independent of sequelae from their former trabecular osteoporosis.


Subject(s)
Calcium/metabolism , Phosphorus/metabolism , Aged , Aged, 80 and over , Aging , Female , Humans , Institutionalization , Male , Osteoporosis/metabolism , Parathyroid Hormone/blood , Sex Factors , Vitamin D/blood
12.
Int J Pediatr Nephrol ; 7(1): 55-8, 1986.
Article in English | MEDLINE | ID: mdl-3007383

ABSTRACT

In this report, we describe the development of a rapidly progressive Epstein-Barr virus (EBV) related cerebral lymphoma in an 11 year old girl, eight months after renal transplantation. No serological evidence for a persistent EBV infection was found, but Epstein-Barr nuclear antigen (EBNA) could be demonstrated in the tumor. The clinical course of our patient was different from EBV-related syndromes in renal transplanted patients described in previous reports. Furthermore, pathological investigations of the biopsy specimen and tumor cells obtained at necropsy revealed a discrepancy in light chain expression. The possibility that lymphoproliferative disorders represent multiclonal B cell lymphomas is discussed.


Subject(s)
Brain Neoplasms/etiology , Burkitt Lymphoma/etiology , Kidney Transplantation , Antigens, Viral/immunology , B-Lymphocytes/immunology , Brain Neoplasms/immunology , Burkitt Lymphoma/immunology , Child , Epstein-Barr Virus Nuclear Antigens , Female , Herpesvirus 4, Human/immunology , Humans , Time Factors
13.
IARC Sci Publ ; (30): 783-93, 1980.
Article in English | MEDLINE | ID: mdl-7228335

ABSTRACT

Annual chest radiographs, work history and mortality of 1,973 workers in an asbestos-cement factory were correlated with age and with duration and level of dust exposure. Degree of radiographic lung change was significantly related to fibre-years of exposure in the case of small lung opacities, pleural adhesions and pleural thickening. For 29 cases of asbestosis diagnosed between 1963 and 1977, a highly significant dose-response relationship was found. In comparison with national mortality rates, there was an excess of deaths due to cancer of the gastrointestinal tract, although there was no relationship to fibre-years.


Subject(s)
Asbestosis/diagnostic imaging , Lung/diagnostic imaging , Adolescent , Adult , Age Factors , Aged , Asbestos , Asbestosis/epidemiology , Asbestosis/mortality , Belgium , Humans , Lung/pathology , Male , Middle Aged , Occupational Diseases/epidemiology , Occupational Diseases/mortality , Pleura/diagnostic imaging , Pleura/pathology , Radiography , Time Factors
14.
Dev Biol Stand ; 46: 97-100, 1980.
Article in English | MEDLINE | ID: mdl-7364157

ABSTRACT

A disposable pyrogen-free centrifuge bowl is described for continuous asceptic separation of cells from cultures up to 50 litres.


Subject(s)
Cell Separation/instrumentation , Centrifugation/instrumentation , Animals , Asepsis , Cell Line , Cell Survival , Cricetinae , Kidney
SELECTION OF CITATIONS
SEARCH DETAIL
...